GEM 231: Phase I data; Phase II

In 26 patients with advanced cancers in 2 ongoing U.S. Phase

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE